Elanco Animal Health Inc (NYSE: ELAN) open the trading on Thursday, with a bit cautious approach as it glided -0.96% to $12.39, before settling in for the price of $12.51 at the close. Taking a more long-term approach, ELAN posted a 52-week range of $8.52-$18.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 9.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 3.31%. This publicly-traded company’s shares outstanding now amounts to $492.85 million, simultaneously with a float of $488.20 million. The organization now has a market capitalization sitting at $6.12 billion. At the time of writing, stock’s 50-day Moving Average stood at $14.34, while the 200-day Moving Average is $15.05.
Elanco Animal Health Inc (ELAN) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – Specialty & Generic industry. Elanco Animal Health Inc’s current insider ownership accounts for 1.24%, in contrast to 97.87% institutional ownership. According to the most recent insider trade that took place on Aug 22 ’24, this organization’s Director bought 3,500 shares at the rate of 14.85, making the entire transaction reach 51,974 in total value, affecting insider ownership by 81,094. Preceding that transaction, on Aug 12 ’24, Company’s PRESIDENT, CEO AND DIRECTOR bought 100,000 for 13.01, making the whole transaction’s value amount to 1,300,610. This particular insider is now the holder of 145,000 in total.
Elanco Animal Health Inc (ELAN) Earnings and Revenue Records
Elanco Animal Health Inc’s EPS increase for this current 12-month fiscal period is 3.31% and is forecasted to reach 0.96 in the upcoming year.
Elanco Animal Health Inc (NYSE: ELAN) Trading Performance Indicators
Let’s observe the current performance indicators for Elanco Animal Health Inc (ELAN). It’s Quick Ratio in the last reported quarter now stands at 1.75. The Stock has managed to achieve an average true range (ATR) of 0.50. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.36. Similarly, its price to free cash flow for trailing twelve months is now 14.41.
In the same vein, ELAN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.55, a figure that is expected to reach 0.12 in the next quarter, and analysts are predicting that it will be 0.96 at the market close of one year from today.
Technical Analysis of Elanco Animal Health Inc (ELAN)
[Elanco Animal Health Inc, ELAN] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 10.37% While, its Average True Range was 0.47.
Raw Stochastic average of Elanco Animal Health Inc (ELAN) in the period of the previous 100 days is set at 13.38%, which indicates a major rise in contrast to 4.43% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 25.43% that was lower than 50.10% volatility it exhibited in the past 100-days period.
